Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 20 | 2024 | 80 | 4.510 |
Why?
|
| Diabetes Mellitus, Type 2 | 17 | 2024 | 760 | 3.710 |
Why?
|
| Prediabetic State | 6 | 2024 | 53 | 2.770 |
Why?
|
| Postmenopause | 24 | 2022 | 267 | 2.680 |
Why?
|
| Weight Loss | 7 | 2020 | 321 | 1.920 |
Why?
|
| Women's Health | 20 | 2023 | 207 | 1.900 |
Why?
|
| Humans | 93 | 2024 | 18430 | 1.670 |
Why?
|
| Obesity | 12 | 2023 | 855 | 1.630 |
Why?
|
| Cholecalciferol | 9 | 2019 | 15 | 1.580 |
Why?
|
| Female | 79 | 2024 | 13136 | 1.570 |
Why?
|
| Accidental Falls | 4 | 2015 | 40 | 1.530 |
Why?
|
| Menopause | 6 | 2020 | 72 | 1.450 |
Why?
|
| Hypoglycemic Agents | 4 | 2024 | 288 | 1.420 |
Why?
|
| Aged | 58 | 2020 | 6417 | 1.400 |
Why?
|
| Fractures, Bone | 7 | 2022 | 91 | 1.380 |
Why?
|
| Vitamins | 7 | 2024 | 65 | 1.330 |
Why?
|
| Dietary Supplements | 13 | 2020 | 88 | 1.310 |
Why?
|
| Mass Screening | 4 | 2022 | 690 | 1.250 |
Why?
|
| Risk Factors | 40 | 2024 | 3449 | 1.240 |
Why?
|
| Vitamin D Deficiency | 4 | 2015 | 22 | 1.220 |
Why?
|
| Calcium Carbonate | 6 | 2019 | 9 | 1.150 |
Why?
|
| Prenatal Care | 2 | 2020 | 134 | 1.140 |
Why?
|
| Cognition | 6 | 2013 | 82 | 1.090 |
Why?
|
| Osteoporotic Fractures | 6 | 2017 | 40 | 1.030 |
Why?
|
| Exercise Therapy | 3 | 2015 | 74 | 1.000 |
Why?
|
| Calcium, Dietary | 5 | 2017 | 28 | 0.990 |
Why?
|
| Middle Aged | 47 | 2021 | 8284 | 0.990 |
Why?
|
| Behavior Therapy | 4 | 2021 | 155 | 0.990 |
Why?
|
| Prospective Studies | 23 | 2023 | 1314 | 0.940 |
Why?
|
| Estrogen Replacement Therapy | 7 | 2017 | 104 | 0.940 |
Why?
|
| Metformin | 2 | 2022 | 61 | 0.930 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 630 | 0.890 |
Why?
|
| Aging | 4 | 2015 | 165 | 0.880 |
Why?
|
| Hip Fractures | 6 | 2016 | 68 | 0.860 |
Why?
|
| Testosterone | 3 | 2014 | 22 | 0.860 |
Why?
|
| Estradiol | 4 | 2014 | 24 | 0.850 |
Why?
|
| Calcium | 6 | 2020 | 34 | 0.830 |
Why?
|
| Hot Flashes | 6 | 2020 | 39 | 0.820 |
Why?
|
| Estrogens | 5 | 2022 | 73 | 0.810 |
Why?
|
| Dementia | 3 | 2020 | 105 | 0.800 |
Why?
|
| Glycated Hemoglobin A | 3 | 2020 | 233 | 0.770 |
Why?
|
| Weight Gain | 6 | 2020 | 181 | 0.760 |
Why?
|
| Health Behavior | 5 | 2021 | 374 | 0.760 |
Why?
|
| Anti-Obesity Agents | 2 | 2018 | 18 | 0.740 |
Why?
|
| Aged, 80 and over | 17 | 2019 | 2003 | 0.710 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2016 | 23 | 0.680 |
Why?
|
| Incidence | 14 | 2019 | 1314 | 0.670 |
Why?
|
| Cognitive Dysfunction | 2 | 2016 | 47 | 0.660 |
Why?
|
| Preconception Care | 2 | 2016 | 48 | 0.650 |
Why?
|
| Breast Density | 4 | 2022 | 31 | 0.650 |
Why?
|
| Obesity Management | 1 | 2018 | 4 | 0.640 |
Why?
|
| Pregnancy Complications | 2 | 2021 | 193 | 0.620 |
Why?
|
| Gonadal Steroid Hormones | 3 | 2016 | 33 | 0.600 |
Why?
|
| Body Mass Index | 15 | 2023 | 974 | 0.590 |
Why?
|
| Cohort Studies | 16 | 2020 | 2672 | 0.590 |
Why?
|
| Demography | 1 | 2017 | 108 | 0.580 |
Why?
|
| Femoral Fractures | 1 | 2017 | 22 | 0.580 |
Why?
|
| Menstruation | 1 | 2017 | 8 | 0.570 |
Why?
|
| Follow-Up Studies | 15 | 2023 | 1269 | 0.570 |
Why?
|
| Primary Health Care | 2 | 2015 | 848 | 0.570 |
Why?
|
| United States | 22 | 2019 | 4164 | 0.570 |
Why?
|
| Reproductive History | 1 | 2017 | 18 | 0.570 |
Why?
|
| Bone Density Conservation Agents | 2 | 2014 | 55 | 0.560 |
Why?
|
| Male | 17 | 2024 | 10440 | 0.560 |
Why?
|
| Adult | 19 | 2022 | 7910 | 0.550 |
Why?
|
| Cross-Sectional Studies | 11 | 2024 | 1360 | 0.540 |
Why?
|
| Breast | 4 | 2019 | 84 | 0.530 |
Why?
|
| Blood Glucose | 5 | 2024 | 346 | 0.530 |
Why?
|
| Residence Characteristics | 2 | 2017 | 256 | 0.520 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 60 | 0.510 |
Why?
|
| Treatment Outcome | 10 | 2021 | 1296 | 0.500 |
Why?
|
| Pregnancy | 8 | 2024 | 1516 | 0.500 |
Why?
|
| Diet | 4 | 2021 | 371 | 0.490 |
Why?
|
| Body Composition | 3 | 2023 | 82 | 0.470 |
Why?
|
| Time Factors | 9 | 2019 | 1136 | 0.470 |
Why?
|
| Diphosphonates | 1 | 2014 | 62 | 0.460 |
Why?
|
| Double-Blind Method | 9 | 2019 | 165 | 0.450 |
Why?
|
| Macular Degeneration | 4 | 2015 | 19 | 0.450 |
Why?
|
| Drug Compounding | 1 | 2013 | 4 | 0.440 |
Why?
|
| Nonprescription Drugs | 1 | 2013 | 6 | 0.440 |
Why?
|
| Bone Density | 6 | 2019 | 96 | 0.440 |
Why?
|
| Breast Neoplasms | 8 | 2022 | 1037 | 0.420 |
Why?
|
| Proportional Hazards Models | 11 | 2019 | 743 | 0.400 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2023 | 342 | 0.380 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2017 | 412 | 0.360 |
Why?
|
| Spinal Fractures | 3 | 2016 | 12 | 0.360 |
Why?
|
| Surveys and Questionnaires | 8 | 2019 | 1389 | 0.350 |
Why?
|
| Health Status Disparities | 1 | 2011 | 153 | 0.350 |
Why?
|
| Overweight | 4 | 2016 | 276 | 0.340 |
Why?
|
| Adolescent | 8 | 2022 | 3798 | 0.340 |
Why?
|
| Osteoporosis, Postmenopausal | 4 | 2019 | 44 | 0.340 |
Why?
|
| Sleep | 2 | 2019 | 57 | 0.330 |
Why?
|
| Body Weight | 3 | 2020 | 223 | 0.330 |
Why?
|
| Preventive Health Services | 2 | 2022 | 166 | 0.330 |
Why?
|
| Menarche | 2 | 2019 | 30 | 0.310 |
Why?
|
| Sweating | 3 | 2017 | 9 | 0.300 |
Why?
|
| Exercise | 3 | 2021 | 495 | 0.290 |
Why?
|
| Child | 7 | 2023 | 2571 | 0.280 |
Why?
|
| Neoplasms | 4 | 2016 | 457 | 0.280 |
Why?
|
| Life Style | 3 | 2015 | 342 | 0.270 |
Why?
|
| Fetal Macrosomia | 3 | 2021 | 27 | 0.260 |
Why?
|
| Age Factors | 5 | 2016 | 965 | 0.260 |
Why?
|
| Adiposity | 2 | 2023 | 67 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 105 | 0.250 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 150 | 0.250 |
Why?
|
| Self Report | 5 | 2019 | 256 | 0.250 |
Why?
|
| Risk Assessment | 5 | 2017 | 1143 | 0.250 |
Why?
|
| Emotions | 2 | 2015 | 35 | 0.250 |
Why?
|
| Fatigue | 2 | 2015 | 35 | 0.250 |
Why?
|
| Sleep Wake Disorders | 2 | 2015 | 38 | 0.240 |
Why?
|
| Sex Characteristics | 1 | 2024 | 70 | 0.240 |
Why?
|
| Diet, Reducing | 3 | 2015 | 27 | 0.240 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 38 | 0.230 |
Why?
|
| Retrospective Studies | 6 | 2017 | 2550 | 0.230 |
Why?
|
| Carotenoids | 2 | 2014 | 29 | 0.230 |
Why?
|
| Patient Compliance | 2 | 2016 | 318 | 0.220 |
Why?
|
| Body Size | 2 | 2020 | 31 | 0.220 |
Why?
|
| Sex Factors | 1 | 2024 | 661 | 0.210 |
Why?
|
| Osteoporosis | 2 | 2014 | 76 | 0.210 |
Why?
|
| Young Adult | 5 | 2022 | 2518 | 0.210 |
Why?
|
| Advisory Committees | 1 | 2022 | 112 | 0.190 |
Why?
|
| Premature Birth | 1 | 2023 | 138 | 0.190 |
Why?
|
| Geriatric Assessment | 2 | 2012 | 40 | 0.190 |
Why?
|
| Odds Ratio | 8 | 2017 | 701 | 0.190 |
Why?
|
| Pregnancy Trimesters | 1 | 2020 | 29 | 0.180 |
Why?
|
| Glycemic Load | 1 | 2020 | 1 | 0.180 |
Why?
|
| Glycemic Index | 1 | 2020 | 21 | 0.180 |
Why?
|
| Sexual Maturation | 1 | 2019 | 8 | 0.170 |
Why?
|
| Adipose Tissue | 2 | 2018 | 60 | 0.170 |
Why?
|
| Anthropometry | 1 | 2020 | 67 | 0.170 |
Why?
|
| Drug Administration Schedule | 3 | 2014 | 100 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 530 | 0.170 |
Why?
|
| Contraceptives, Oral | 1 | 1999 | 26 | 0.170 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 39 | 0.170 |
Why?
|
| Counseling | 1 | 2021 | 197 | 0.170 |
Why?
|
| Parity | 1 | 2019 | 74 | 0.170 |
Why?
|
| Hispanic Americans | 3 | 2021 | 428 | 0.170 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 159 | 0.170 |
Why?
|
| Puberty | 1 | 2019 | 58 | 0.160 |
Why?
|
| Cholesterol, LDL | 2 | 2017 | 125 | 0.160 |
Why?
|
| Logistic Models | 3 | 2016 | 962 | 0.160 |
Why?
|
| Dietary Fats | 2 | 2016 | 92 | 0.160 |
Why?
|
| Bias | 1 | 2018 | 111 | 0.150 |
Why?
|
| Health Promotion | 1 | 2021 | 294 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2019 | 133 | 0.150 |
Why?
|
| European Continental Ancestry Group | 3 | 2017 | 554 | 0.150 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2017 | 16 | 0.150 |
Why?
|
| Ovariectomy | 1 | 2017 | 9 | 0.150 |
Why?
|
| Feeding Behavior | 2 | 2016 | 168 | 0.150 |
Why?
|
| Receptors, Neurokinin-3 | 1 | 2017 | 1 | 0.150 |
Why?
|
| Body Weights and Measures | 1 | 2017 | 13 | 0.150 |
Why?
|
| Hysterectomy | 1 | 2017 | 30 | 0.140 |
Why?
|
| Public Health Surveillance | 1 | 2017 | 45 | 0.140 |
Why?
|
| Biomarkers | 2 | 2015 | 308 | 0.140 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 39 | 0.140 |
Why?
|
| Calcifediol | 2 | 2014 | 3 | 0.140 |
Why?
|
| Body Height | 2 | 2018 | 62 | 0.140 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2016 | 2 | 0.140 |
Why?
|
| Diet, Mediterranean | 1 | 2016 | 7 | 0.140 |
Why?
|
| Pregnancy Rate | 1 | 2016 | 5 | 0.140 |
Why?
|
| Reproduction | 1 | 2016 | 12 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2015 | 7 | 0.130 |
Why?
|
| Complement Factor I | 1 | 2015 | 1 | 0.130 |
Why?
|
| Cause of Death | 2 | 2019 | 185 | 0.130 |
Why?
|
| Age of Onset | 1 | 2015 | 82 | 0.130 |
Why?
|
| Institutionalization | 1 | 2015 | 1 | 0.130 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 673 | 0.130 |
Why?
|
| Homes for the Aged | 1 | 2015 | 6 | 0.130 |
Why?
|
| Vasomotor System | 1 | 2014 | 5 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 146 | 0.120 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 29 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 133 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 7 | 0.120 |
Why?
|
| African Americans | 2 | 2017 | 490 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2020 | 747 | 0.120 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 724 | 0.120 |
Why?
|
| Insulin | 1 | 2015 | 208 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 69 | 0.120 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 58 | 0.120 |
Why?
|
| Oregon | 1 | 2014 | 222 | 0.120 |
Why?
|
| Risk | 2 | 2009 | 552 | 0.120 |
Why?
|
| Mortality | 1 | 2015 | 123 | 0.120 |
Why?
|
| Hand Strength | 1 | 2013 | 11 | 0.110 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 78 | 0.110 |
Why?
|
| Memory | 1 | 2013 | 12 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 177 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 182 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 167 | 0.110 |
Why?
|
| Washington | 1 | 2014 | 388 | 0.110 |
Why?
|
| Cognition Disorders | 2 | 2012 | 32 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 180 | 0.110 |
Why?
|
| Retinal Pigments | 1 | 2013 | 3 | 0.110 |
Why?
|
| Asian Americans | 1 | 2014 | 182 | 0.110 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2012 | 1 | 0.110 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2012 | 2 | 0.110 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2012 | 4 | 0.110 |
Why?
|
| Walking | 1 | 2013 | 87 | 0.110 |
Why?
|
| Research Design | 2 | 2011 | 402 | 0.100 |
Why?
|
| Thyroid Diseases | 1 | 2012 | 2 | 0.100 |
Why?
|
| Thyroxine | 1 | 2012 | 5 | 0.100 |
Why?
|
| Thyroid Gland | 1 | 2012 | 5 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 444 | 0.100 |
Why?
|
| Thyrotropin | 1 | 2012 | 8 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2023 | 872 | 0.100 |
Why?
|
| Lactones | 1 | 2011 | 11 | 0.100 |
Why?
|
| Early Medical Intervention | 1 | 2011 | 10 | 0.100 |
Why?
|
| World Health Organization | 1 | 2011 | 15 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2011 | 23 | 0.100 |
Why?
|
| Models, Biological | 1 | 2011 | 32 | 0.100 |
Why?
|
| Prevalence | 4 | 2016 | 911 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2014 | 267 | 0.100 |
Why?
|
| Absorptiometry, Photon | 2 | 2023 | 52 | 0.100 |
Why?
|
| Diabetes, Gestational | 2 | 2021 | 339 | 0.090 |
Why?
|
| Melanoma | 1 | 2011 | 37 | 0.090 |
Why?
|
| Survival Rate | 1 | 2011 | 269 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 109 | 0.090 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 162 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 64 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 195 | 0.090 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 119 | 0.090 |
Why?
|
| Mammography | 2 | 2022 | 174 | 0.090 |
Why?
|
| Administration, Oral | 2 | 2020 | 86 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2017 | 1173 | 0.070 |
Why?
|
| Depression | 1 | 2012 | 518 | 0.070 |
Why?
|
| Sleep Deprivation | 1 | 2007 | 4 | 0.070 |
Why?
|
| Stroke | 2 | 2019 | 311 | 0.070 |
Why?
|
| Phenotype | 2 | 2019 | 148 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2019 | 131 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 656 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 476 | 0.060 |
Why?
|
| Genotype | 2 | 2015 | 253 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 598 | 0.060 |
Why?
|
| Prognosis | 2 | 2011 | 624 | 0.060 |
Why?
|
| Maternal Age | 1 | 2021 | 80 | 0.050 |
Why?
|
| Cesarean Section | 1 | 2021 | 30 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2001 | 69 | 0.050 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2021 | 41 | 0.050 |
Why?
|
| Dementia, Vascular | 1 | 2020 | 5 | 0.040 |
Why?
|
| Fasting | 1 | 2020 | 48 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2020 | 38 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2020 | 106 | 0.040 |
Why?
|
| Thinness | 1 | 2020 | 29 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2020 | 71 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 21 | 0.040 |
Why?
|
| Hip Joint | 1 | 2019 | 4 | 0.040 |
Why?
|
| Femur Neck | 1 | 2019 | 6 | 0.040 |
Why?
|
| Actigraphy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 36 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2021 | 112 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 57 | 0.040 |
Why?
|
| Biopsy | 1 | 1999 | 75 | 0.040 |
Why?
|
| Probability | 1 | 2018 | 86 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 337 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 1999 | 249 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 6 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 6 | 0.040 |
Why?
|
| Metabolomics | 1 | 2017 | 8 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2017 | 3 | 0.040 |
Why?
|
| Protective Factors | 1 | 2017 | 33 | 0.040 |
Why?
|
| Intention | 1 | 2017 | 28 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2017 | 60 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 19 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 50 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 31 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 48 | 0.030 |
Why?
|
| Complement Factor B | 1 | 2015 | 1 | 0.030 |
Why?
|
| Complement C3 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Complement Factor H | 1 | 2015 | 2 | 0.030 |
Why?
|
| Proteins | 1 | 2015 | 15 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 252 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2015 | 26 | 0.030 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2015 | 5 | 0.030 |
Why?
|
| E-Selectin | 1 | 2015 | 2 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 157 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2014 | 2 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 4 | 0.030 |
Why?
|
| Cytokines | 1 | 2014 | 30 | 0.030 |
Why?
|
| Fetal Development | 1 | 2014 | 14 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 112 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2014 | 80 | 0.030 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 1 | 2013 | 1 | 0.030 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2013 | 1 | 0.030 |
Why?
|
| Urinary Calculi | 1 | 2012 | 1 | 0.030 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 310 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 35 | 0.030 |
Why?
|
| Sunlight | 1 | 2012 | 16 | 0.030 |
Why?
|
| Edible Grain | 1 | 2012 | 14 | 0.030 |
Why?
|
| Comorbidity | 1 | 2014 | 619 | 0.030 |
Why?
|
| Seasons | 1 | 2012 | 105 | 0.030 |
Why?
|
| Fruit | 1 | 2012 | 79 | 0.030 |
Why?
|
| Vegetables | 1 | 2012 | 87 | 0.030 |
Why?
|
| Thyroid Function Tests | 1 | 2012 | 3 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2011 | 9 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 16 | 0.020 |
Why?
|
| Ethnic Groups | 1 | 2015 | 501 | 0.020 |
Why?
|
| Confounding Factors (Epidemiology) | 1 | 2011 | 99 | 0.020 |
Why?
|
| Zeaxanthins | 1 | 2010 | 5 | 0.020 |
Why?
|
| Tocopherols | 1 | 2010 | 5 | 0.020 |
Why?
|
| Xanthophylls | 1 | 2010 | 6 | 0.020 |
Why?
|
| Lutein | 1 | 2010 | 7 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 11 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 58 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 215 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2009 | 1 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2012 | 315 | 0.020 |
Why?
|
| Animals | 1 | 2009 | 261 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2009 | 185 | 0.020 |
Why?
|
Concepts
(308)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->